arrow
C

Caterina Lapucci

irccs ospedale policlinico san martino
H指数:22
被引数:1,669

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Functional and effective connectivity alterations relate to cognitive performance in aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder

AQP4抗体阳性视神经脊髓炎谱系障碍中功能与有效连接的改变与认知表现相关

2026-09-010
OAAI
A two-year single-site longitudinal assessment of brain and retinal atrophy in ocrelizumab-treated relapsing–remitting multiple sclerosis

奥瑞利珠单抗治疗缓解期多发性硬化患者脑和视网膜萎缩的两年单中心纵向评估

2026-08-270
OAAI
Corrigendum to “Treatment discontinuation in older patients with multiple sclerosis” [Multiple Sclerosis and Related Disorders, Volume 103, November 2025, 106741]

更正:“多发性硬化症老年患者治疗中断”[多发性硬化症及相关疾病,第103卷,2025年11月,106741]

2026-04-110
PRE
The early effect of induction versus continuous therapies in active multiple sclerosis: a multimodal study on the first course of cladribine versus fingolimod

诱导疗法与连续疗法在活动性多发性硬化中的早期效果:一项关于克拉屈滨与芬戈莫德首疗程的多模式研究

2025-08-090
OAAI
Ocrelizumab in MS patients with persistence of disease activity after alemtuzumab: A multi-center Italian study

Ocrelizumab在阿仑单抗治疗后疾病活动持续存在的MS患者中: 一项多中心意大利研究

2024-08-140
PRE
Tissue factor as a potential coagulative/vascular marker in relapsing-remitting multiple sclerosis

组织因子作为复发-缓解型多发性硬化症的潜在凝血/血管标志物

2023-07-312
OAAI
Multicenter Evaluation of AI-generated DIR and PSIR for Cortical and Juxtacortical Multiple Sclerosis Lesion Detection

AI生成的DIR和PSIR用于皮质和皮质多发性硬化病变检测的多中心评估

RADIOLOGY
IF15.2
2023-04-0118
OAAI